News

A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.
The positron emission tomography (PET) scanners products market is expected to reach USD 1,441.5 million by 2025 and is expected to steadily grow at a CAGR of 5.3% to reach USD 2,415.9 million by 2035 ...
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...
Positron emission tomography (PET) is a nuclear medicine medical imaging technique which produces a three dimensional image or map of functional processes in the body. PET is both a medical and ...
Positron Emission Tomography (PET) Scanners Global Market Overview 2021-2023 & 2024-2030 - ResearchAndMarkets.com February 17, 2025 10:25 AM Eastern Standard Time ...
Open in Viewer Fig 1. Patient flow diagram. ccRCC, clear cell renal cell carcinoma; CECT, contrast-enhanced computed tomography; IP, investigational product; PET/CT, positron emission ...
PURPOSE: Although positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (18 F-FDG) has a major impact on the treatment of adult cancer, the reported experience with extracranial ...
3. Sazon, DAD, Santiago, SM, Soo Hoo, GW, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996;153:417-421 ...
The use of positron emission tomography (PET) imaging may help identify findings in brain tissue associated with Alzheimer's disease (AD), according to two articles.